P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Bibliographic Details
Main Authors: M Callaghan, K Ataga, L De Franceschi, C Minniti, N Balachandran, D Imbs, T Perretti, J Ramos, A Sostelly, P Bartolucci
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000821572.78026.e4

Internet

http://journals.lww.com/10.1097/01.HS9.0000821572.78026.e4

Similar Items